Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 489

1.

Sofosbuvir for chronic hepatitis C virus infection genotype 1-4 in patients co-infected with HIV.

Rodriguez-Torres M, Gaggar A, Shen G, Kirby B, Svarovskaia E, Brainard D, Symonds WT, McHutchison JG, Gonzalez M, Rodriguez-Orengo J.

J Acquir Immune Defic Syndr. 2015 Jan 23. [Epub ahead of print]

PMID:
25622055
[PubMed - as supplied by publisher]
2.

Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: a report of three cases.

Righi E, Londero A, Pea F, Bonora S, Nasta P, Della Siega P, Delle Foglie P, Villa G, Giglio O, Dal Zoppo S, Baccarani U, Bassetti M.

Transpl Infect Dis. 2015 Feb;17(1):147-53. doi: 10.1111/tid.12339. Epub 2015 Jan 12.

PMID:
25620392
[PubMed - in process]
3.

Prioritization of New Oral Hepatitis C Therapies for HIV Patients.

Barreiro P, Fernández-Montero JV, Soriano V.

AIDS Rev. 2015 Jan 22;17(1). [Epub ahead of print]

PMID:
25608471
[PubMed - as supplied by publisher]
4.
5.

Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.

Rockstroh JK.

Liver Int. 2015 Jan;35 Suppl 1:51-5. doi: 10.1111/liv.12721.

PMID:
25529087
[PubMed - in process]
6.

Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs.

Puoti M, Panzeri C, Rossotti R, Baiguera C.

Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S206-11. doi: 10.1016/j.dld.2014.09.027. Epub 2014 Nov 7.

PMID:
25458781
[PubMed - in process]
Free Article
7.

Management of acute and chronic HCV infection in persons with HIV coinfection.

Sulkowski MS.

J Hepatol. 2014 Nov;61(1 Suppl):S108-19. doi: 10.1016/j.jhep.2014.08.006. Epub 2014 Nov 3.

PMID:
25443339
[PubMed - in process]
Free Article
8.

Prevalence of Drug-Drug Interactions upon Addition of Simeprevir- or Sofosbuvir-Containing Treatment to Medication Profiles of Patients with HIV and Hepatitis C Coinfection.

Patel N, Nasiri M, Koroglu A, Amin R, McGuey L, McNutt L, Roman M, Miller C.

AIDS Res Hum Retroviruses. 2014 Nov 28. [Epub ahead of print]

PMID:
25432275
[PubMed - as supplied by publisher]
9.

The role of drug transporters in the kidney: lessons from tenofovir.

Moss DM, Neary M, Owen A.

Front Pharmacol. 2014 Nov 11;5:248. doi: 10.3389/fphar.2014.00248. eCollection 2014. Review.

PMID:
25426075
[PubMed]
Free PMC Article
10.

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression.

Llibre JM, Cozzi-Lepri A, La Rosa JA, Pedersen C, Ristola M, Losso M, Mocroft A, Mitsura VM, Ormaasen V, Maltez F, Beniowski M, Paredes R; Eurosida in Eurocoord.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19810. doi: 10.7448/IAS.17.4.19810. eCollection 2014.

PMID:
25397554
[PubMed - in process]
Free PMC Article
11.

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment.

Ehret R, Walter H, Ingiliz P, Baumgarten A, Obermeier M, Krznaric I.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19644. doi: 10.7448/IAS.17.4.19644. eCollection 2014.

PMID:
25394148
[PubMed - in process]
Free PMC Article
12.

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC.

AIDS. 2015 Jan 2;29(1):53-8. doi: 10.1097/QAD.0000000000000516.

PMID:
25387314
[PubMed - in process]
13.

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G.

New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1.

PMID:
25387281
[PubMed - indexed for MEDLINE]
Free Article
14.

Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.

González-Colominas E, Broquetas T, Retamero A, García-Retortillo M, Cañete N, Coll S, Pellicer R, Giménez MD, Cabrero B, Bory F, Knobel H, Salas E, Solà R, Carrión JA.

Liver Int. 2014 Nov 10. doi: 10.1111/liv.12729. [Epub ahead of print]

PMID:
25385188
[PubMed - as supplied by publisher]
15.

Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers.

Joseph D, Rose P, Strelkowa N, Schultz A, Garcia J, Elgadi M, Huang F.

J Clin Pharmacol. 2014 Oct 28. doi: 10.1002/jcph.418. [Epub ahead of print]

PMID:
25352040
[PubMed - as supplied by publisher]
16.

The clinical management of HCV in the HIV-infected patient.

Norton B, Naggie S.

Antivir Ther. 2014 Oct 27. doi: 10.3851/IMP2910. [Epub ahead of print]

PMID:
25346056
[PubMed - as supplied by publisher]
17.

How will we manage acute HCV in men having sex with men in the era of all oral therapy?

Boesecke C, Rockstroh JK.

J Viral Hepat. 2015 Jan;22(1):2-7. doi: 10.1111/jvh.12348. Epub 2014 Oct 21.

PMID:
25333810
[PubMed - in process]
18.

Extensive double humanization of both liver and hematopoiesis in FRGN mice.

Wilson EM, Bial J, Tarlow B, Bial G, Jensen B, Greiner DL, Brehm MA, Grompe M.

Stem Cell Res. 2014 Sep 6;13(3PA):404-412. doi: 10.1016/j.scr.2014.08.006. [Epub ahead of print]

PMID:
25310256
[PubMed - as supplied by publisher]
Free Article
19.

Current status of kidney transplantation in HIV-infected patients.

Sawinski D, Bloom RD.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):619-24. doi: 10.1097/MNH.0000000000000071.

PMID:
25295961
[PubMed - in process]
20.

[New hepatitis C treatments: pharmacological considerations and potential for drug interactions].

Chtioui H, Buclin T, Moradpour D.

Rev Med Suisse. 2014 Sep 3;10(440):1600-4, 1606. French.

PMID:
25276998
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk